The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
9,284
Sort by:
Oral Solid Pharmaceuticals Market Forecasts to 2034 – Global Analysis By Dosage Form (Tablets, Capsules, Powders & Granules, Lozenges & Pastilles, Pellets & Mini-Tablets, Orally Disintegrating Films, and Other Dosage Forms), Drug Release, Route of Administration, Therapeutic Area, Manufacturing Process, Drug Type, Patient Demographics, End User, Distribution Channel, and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Oral Solid Pharmaceuticals Market is accounted for $585.75 billion in 2026 and is expected to reach $969.41 billion by 2034 growing at a CAGR of 6.5% during th...
May 2026
200 pages
Global Medicinal Refined Corn Oil Market Growth 2026-2032
US$ 3,660.00
The global Medicinal Refined Corn Oil market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. The global pharmaceutica...
May 2026
87 pages
Global Gaucher’s Disease Treatment Market Growth 2026-2032
US$ 3,660.00
The global Gaucher’s Disease Treatment market size is predicted to grow from US$ 1673 million in 2025 to US$ 2153 million in 2032; it is expected to grow at a CAGR of 3.7% from 2026 to 2032. United St...
May 2026
89 pages
Global Hypophosphatasia Treatment Market Growth 2026-2032
US$ 3,660.00
The global Hypophosphatasia Treatment market size is predicted to grow from US$ 483 million in 2025 to US$ 688 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032. United State...
May 2026
86 pages
Global L-Carnosine API Market Growth 2026-2032
US$ 3,660.00
The global L-Carnosine API market size is predicted to grow from US$ 29.01 million in 2025 to US$ 38.88 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032. L-carnosine, also s...
May 2026
89 pages
Global Clazosentan Drug Market Growth 2026-2032
US$ 3,660.00
The global Clazosentan Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. United States market for Clazosent...
May 2026
81 pages
